ZLD 0.00% 75.0¢ zelira therapeutics limited

Dream big with Zelira, page-886

  1. 1,900 Posts.
    lightbulb Created with Sketch. 303
    Exactly. Talk about MOAT or sustainable competitve advantage.
    Australia - R&D rebate, scientists and research has a great global standing
    US - Largest market, Democrates in power for next 3.5 years, Chairman & CEO in USA, & the US market is the single most influential market for the global market. That is in most cases if you make it in the US you generally will do well across to globe. Unless you in the car business LOL
    UK - good relations with Australia & USA hence market access in not an issue

    Without talking rocket ships etc... on a serious note I do believe in Q4 and Q1 2022 this stock will be around 20 cents. Remember for a brief moment it hit 13 cents earlier in 2021 with no revenue and no certainty with the US election results/outcome.
    Products in US market
    SprinJene itoothpaste s the label (cbd toothpaste)
    Hope 1 (Autism)
    Hope 2 (Autism)
    Zenivol - currently Australia only (Insomnia)

    I am probably most excited about Zenivol (huge market). Does anyone know if its approved in the US. I don't think it is but I think the company is trying to get this approved in 2021. The current share price is a good time to top up if you can. I certainly did yesterday. GLTAH
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.